RDHL logo

RedHill Biopharma (RDHL) Company Overview

Profile

Full Name:

RedHill Biopharma Ltd.

Sector:

Healthcare

Country:

Israel

IPO:

January 7, 2013

Indexes:

Not included

Description:

RedHill Biopharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for gastrointestinal diseases and other serious conditions. They aim to improve patient outcomes through advanced treatments and have a strong pipeline of products in various stages of development.

Key Details

Price

$3.28

Annual Revenue

$6.53 M(-89.43% YoY)

Annual EPS

$100.00(+108.33% YoY)

Annual ROE

1155.92%

Beta

0.09

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 5, 2025

Recent annual earnings:

Apr 8, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 22, 2024

Analyst ratings

Recent major analysts updates

Sep 15, 21 HC Wainwright & Co.
Buy
Aug 31, 21 Cantor Fitzgerald
Overweight
May 28, 21 WBB Securities
Buy
May 18, 21 HC Wainwright & Co.
Buy
Sep 11, 20 BTIG
Buy
Mar 5, 20 H.C. Wainwright
Buy
Jul 12, 19 WBB Securities
Strong Buy
Mar 12, 19 WBB Securities
Buy
Jun 25, 18 Ladenburg Thalmann
Buy
Jan 26, 18 Nomura
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for RedHill Biopharma?
  • Does RedHill Biopharma pay dividends?
  • What sector is RedHill Biopharma in?
  • What industry is RedHill Biopharma in?
  • What country is RedHill Biopharma based in?
  • When did RedHill Biopharma go public?
  • Is RedHill Biopharma in the S&P 500?
  • Is RedHill Biopharma in the NASDAQ 100?
  • Is RedHill Biopharma in the Dow Jones?
  • When was RedHill Biopharma's last earnings report?
  • When does RedHill Biopharma report earnings?
  • Should I buy RedHill Biopharma stock now?

What is the ticker symbol for RedHill Biopharma?

The ticker symbol for RedHill Biopharma is NASDAQ:RDHL

Does RedHill Biopharma pay dividends?

No, RedHill Biopharma does not pay dividends

What sector is RedHill Biopharma in?

RedHill Biopharma is in the Healthcare sector

What industry is RedHill Biopharma in?

RedHill Biopharma is in the Drug Manufacturers - Specialty & Generic industry

What country is RedHill Biopharma based in?

RedHill Biopharma is headquartered in Israel

When did RedHill Biopharma go public?

RedHill Biopharma's initial public offering (IPO) was on January 7, 2013

Is RedHill Biopharma in the S&P 500?

No, RedHill Biopharma is not included in the S&P 500 index

Is RedHill Biopharma in the NASDAQ 100?

No, RedHill Biopharma is not included in the NASDAQ 100 index

Is RedHill Biopharma in the Dow Jones?

No, RedHill Biopharma is not included in the Dow Jones index

When was RedHill Biopharma's last earnings report?

RedHill Biopharma's most recent earnings report was on Mar 5, 2025

When does RedHill Biopharma report earnings?

The date for RedHill Biopharma's next earnings report has not been announced yet

Should I buy RedHill Biopharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions